PLIVA - Lachema A.S.

Joint Stock Company
Karasek 1, Brno,  621 33, Czech Republic
()420 541 127 111, 420 541 127 625 fax, http://www.lachema.cz

Primary SIC: Medical Chemicals & Botanical Products, Primary NAICS: Medicinal and Botanical Manufacturing
Description: Manufacturing: Research, development, manufacture and sale of drugs, diagnostic preparations and chemicals

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

PLIVA - Lachema A.S., News and Information

Restructuring of PLIVA's Operations in the Czech Republic.
InPR; 9/23/2009; 471 words; ...the acquisition by Teva of Barr/Pliva, agreement was reached to sell PLIVA-Lachema's diagnostic business and to close...other manufacturing activities at PLIVA-Lachema's Brno site effective end of 2009...

Pliva to divest of Pliva-Lachema's diagnostics ops.
ADP News Czech Republic; 9/21/2009; 458 words; ...the diagnostics operations of its Czech unit Pliva-Lachema, newswire SeeNews reported on Monday. Furthermore...divestment is part of the restructuring of Pliva-Lachema, which is in line with company's efforts to improve efficiency and profitability...

Publication No. WO/2009/100691 Published on Aug. 20, Assigned to PLIVA Lachema for Adamantylamino- Platinum Complex LA- 12 Polymorphic Form (Czech Inventors)
US Fed News Service, Including US State News; 8/25/2009; 407 words; ...polymorphic form (III) of the adamantylamino- platinum (IV) complex LA- 12. The patent has been assigned to PLIVA Lachema A.S., Brno, Czech Republic. According to an abstract posted by the World Intellectual Property Organization, the...

Publication No. WO/2009/100689 Published on Aug. 20, Assigned to PLIVA Lachema for Adamantylamino- Platinum Complex LA-12 Polymorphic Form (Czech Inventors)
US Fed News Service, Including US State News; 8/25/2009; 405 words; ...developed a polymorphic form of adamantylamino- platinum (IV) complex LA-12. The patent has been assigned to PLIVA Lachema A.S., Brno, Czech Republic. According to an abstract posted by the World Intellectual Property Organization, the...

Publication No. WO/2009/100690 Published on Aug. 20, Assigned to PLIVA Lachema for Adamantylamino-Platinum Complex LA-12 Amourphous Form (Czech Inventors)
US Fed News Service, Including US State News; 8/25/2009; 407 words; ...developed an amourphous form of the adamantylamino-platinum (iv) complex LA-12. The patent has been assigned to PLIVA Lachema A.S., Brno, Czech Republic. According to an abstract posted by the World Intellectual Property Organization, the...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.